About Kerrie Brady
Kerrie Brady is a director at Invea Therapeutics.
Kerrie Brady first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Kerrie Brady in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kerrie Brady works with at each company, as listed on that company's latest Form D.
Invea Therapeutics, Inc · Form D, Dec 10, 2025
DK
Demetrios Kydonieus
Director
AK
Aman Kant
President
SA
Salvatore Alesci
Chief Scientific Officer
MA
Michael Aiello
Chief Financial Officer
JZ
Jonathan Zalevsky
Director
SO
Shunichiro "Steve" Okada
Chief Medical Officer
SD
Stephen Doberstein
Director
KN
Krishnan Nandabalan
Chief Executive Officer and Chairman